Panel Discussion | The Road Ahead in EP Innovation

Monday, March 9, 2026

4:40 PM - 5:00 PM EST

Location: Georgetown

Moderator(s)

Samuel Conaway, MBA

President Cardiology Sales
Boston Scientific Corporation
Miami, Florida, United States

Disclosure information not submitted.

Panel Discussant(s)

TB

Todd Butka

Disclosure information not submitted.
Cyrus A. Hadadi, MD

Associate Director of Cardiac Arrhythmia Research
MedStar Heart & Vascular Institute
Washington, District of Columbia, United States

Disclosure information not submitted.
Ken Stein, MD

Senior Vice President and Chief Medical Officer
Boston Scientific
St.Paul, Minnesota, United States

Disclosure information not submitted.
KT

Kamala Tamirisa, MD

Houston Methodist

Disclosure information not submitted.

Disclosure(s):

William T. Abraham, MD: Abbott: Consulting Fees (e.g., advisory boards) (Ongoing); AquaPass: Consulting Fees (e.g., advisory boards) (Ongoing); Bioventrix: Consulting Fees (e.g., advisory boards) (Ongoing); Cardiac Dimensions: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordio Medical: Consulting Fees (e.g., advisory boards) (Ongoing); CVRx: Consulting Fees (e.g., advisory boards) (Ongoing); Impulse Dynamics: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Innoventric: Consulting Fees (e.g., advisory boards) (Ongoing); JNJ V-Wave: Consulting Fees (e.g., advisory boards) (Ongoing); SCPharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated, October 31, 2025), Stock-publicly held company (excluding mutual/index funds) (Terminated, October 31, 2025); Sensible Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Vectorious Medtech: Consulting Fees (e.g., advisory boards) (Ongoing); WhiteSwell: Consulting Fees (e.g., advisory boards) (Ongoing); Zoll Respicardia: Consulting Fees (e.g., advisory boards) (Ongoing)